Pregnancy after catheter-directed thrombolysis for acute iliofemoral deep venous thrombosis

Phlebology

Volumn 28, Issue 1_suppl, 2013, Pages 34-38

  Jorgenseno M ^a   Broholm, R ^b   Baekgaard N ^b  

^a NAESTVED HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

catheter directed thrombolysis; deep venous thrombosis; iliofemoral thrombosis; low molecular weight heparin; pregnancy; tinzaparin

Indexed keywords

ACETYLSALICYLIC ACID; DALTEPARIN; LOW MOLECULAR WEIGHT HEPARIN; TINZAPARIN; WARFARIN; ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT;

ADOLESCENT; ADULT; ANTIPHOSPHOLIPID SYNDROME; CATHETER DIRECTED THROMBOLYSIS; CESAREAN SECTION; CLINICAL ARTICLE; COLOR DOPPLER FLOWMETRY; COMPRESSION STOCKING; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FETUS DEATH; FETUS MALFORMATION; FOLLOW UP; HUMAN; ILIOFEMORAL VEIN; IN-STENT RESTENOSIS; INDIVIDUALIZATION; INTERNATIONAL NORMALIZED RATIO; INTRAUTERINE GROWTH RETARDATION; INTRAUTERINE INFECTION; LUNG EMBOLISM; MECHANICAL THROMBECTOMY; MEDICAL DEVICE COMPLICATION; MEDICATION ERROR; OBSTETRIC DELIVERY; PREGNANCY; PREGNANCY TERMINATION; PRESCRIPTION; PRIORITY JOURNAL; PUERPERIUM; REVIEW; RISK ASSESSMENT; RISK FACTOR; STENT; TERATOGENICITY; THROMBOPHILIA; TREATMENT DURATION; VAGINAL DELIVERY; VEIN; ACUTE DISEASE; ARTICLE; CATHETERIZATION; COLOR ULTRASOUND FLOWMETRY; DRUG ADMINISTRATION; DRUG MONITORING; ECHOGRAPHY; FEMORAL VEIN; FIBRINOLYTIC THERAPY; ILIAC VEIN; METHODOLOGY; PREGNANCY COMPLICATION; TIME; TREATMENT OUTCOME; VEIN THROMBOSIS;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTICOAGULANTS; CATHETERIZATION, PERIPHERAL; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; DRUG SUBSTITUTION; FEMALE; FEMORAL VEIN; FIBRINOLYTIC AGENTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; ILIAC VEIN; INTERNATIONAL NORMALIZED RATIO; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RISK ASSESSMENT; RISK FACTORS; STENTS; STOCKINGS, COMPRESSION; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, COLOR; VENOUS THROMBOSIS; WARFARIN; YOUNG ADULT;

EID: 84883196023     PISSN: 02683555     EISSN: 14333031     Source Type: Journal    
DOI: 10.1177/0268355513477286     Document Type: Review

References (19)

1. Rosendahl FR. Risk factors for venous thrombosis: prevalence, risk and interaction. Semin Hematol 1997; 34: 171–87
2. Hansson PO, Welin L, Tibblin G, Eriksson H. Deep vein thrombosis and pulmonary embolism in the general population. Arch Intern Med 1997; 157: 1665–70
3. Anderson FA, Wheeler HB, Goldberg RJ. A population-based perspective on the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 1991; 151: 933–8
4. Hansson PO, Sörbo J, Eriksson H. Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Arch Intern Med 2000; 160: 769–74
5. Prandoni P, Noventa F, Ghirarduzzi A. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. Haematologica 2007; 92: 199–205
6. Heit JA, Kobbervig CE, James AH. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med 2005; 143: 697–706
7. Carrier M, Rodger MA, Wells PS. Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep vein thrombosis: a systematic review and meta-analysis. J Thromb Haemost 2011; 9: 1119–25
8. Enden T, Haig Y, Kløw NE. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (The CaVent study): a randomised controlled trial. Lancet 2012; 379: 31–8
9. Bækgaard N, Broholm R, Just S. Long-term results using catheter-directed thrombolysis in 103 lower limbs with acute iliofemoral venous thrombosis. Eur J Vasc Endovasc Surg 2010; 39: 112–7
10. Jacobsen AF, Skjeldestad FE, Sandset PM. Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium: a register-based case-control study. Am J Obstet Gynecol 2008; 198: 233el–e7
11. Greer IA. Thrombosis in pregnancy: updates in diagnosis and management. Hematology Am Soc Hematol Educ Program 2012: 203–7
12. Greer IA. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood 2005; 106: 401–7
13. Voke J, Keidan J, Pavord S. The management of antenatal venous thromboembolism in the UK and Ireland: a prospective multicentre observational survey. Br J Haematol 2007; 139: 545–58
14. Bauersachs RM, Dudenhausen J, Faridi A. Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women. Thromb Haemost 2007; 98: 1237–45
15. Nelson-Percy C, Powrie R, Borg JY. Tinzaparin use in pregnancy: an international, retrospective study of safety and efficacy profile. Eur J Obstet Gynecol Reprod Biol 2011; 159: 293–9
16. Virkus RA, Lokkegaard EC, Bergholt T. Venous thromboembolism in pregnant and puerperal women in Denmark 1995-2005. A national cohort study. Thromb Haemost 2011; 106: 304–9
17. Bates SH, Greer I A, Middeldorp S. VTE, thrombophilia, antithrombotic therapy, and pregnancy. Chest 2012; 141: 691S–736S
18. Battinelli EM, Bauer KA. Thrombophilias in pregnancy. Hematol Oncol Clin N Am 2011; 25: 323–33
19. Lussana F, Coppens M, Cattaneo M. Pregnancy-related venous thromboembolism: Risk and the effect of thromboprophylaxis. Thromb Res 2012; 129: 673–80